- Fee assured
- Verified this account
This healthcare professional let us know that they are currently available for:
- Phone consultations
- Video consultations
Last updated: 12 Nov 2020
- Movement disorders
- Multiple sclerosis (MS)
- Stroke medicine
UPDATE: During the coronavirus epidemic I am taking on new patients for video or telephone consultations.
I am David Paling, a consultant neurologist with practices at the Royal Hallamshire Hospital in Sheffield, Doncaster Royal Infirmary and Park Hill Hospital.
I am the clinical lead for the internationally renowned MS Centre Sheffield which has been recently featured in BBC Panorama. I am also an honorary senior lecturer at the University of Sheffield, Honorary Strategic Director for the Multiple Sclerosis Academy and the chair of the infrastructure working group of the MS Society.
As well as interests in multiple sclerosis I also specialise in headache and I run a teaching course for local general practitioners on diagnosis and treatments. I am also interested in epilepsy, seizures, blackouts and Parkinson’s disease and I have published peer reviewed articles and chapters on these topics.
I trained at University College London, The University of Manchester and The University of Sydney.
As part of my practice I see patients with all sorts of neurological symptoms including headaches, seizures, blackouts, weakness, numbness, tingling, nerve pains, visual problems, bladder problems, balance problems, walking problems, incoordination and problems with dexterity.
I see people with complicated symptoms which are hard to put together, and ensure that I take the time discuss all of your concerns and symptoms.
I understand that having neurological symptoms and seeing a specialist can be very daunting. I work very hard in my practice to to ensure that I do all I can to put people at their ease, take time to understand their symptoms and their impact, and work together on a investigation and management plan. I regularly survey patients who attend my practise using the RES360 system. The most up to date results are in the outcomes section.
In view of my specialist knowledge I look after patients in a very large geograpical area encompassing Doncaster, Sheffield, Leeds, York, Goole, Beverly, Hull, Barnsley, Rotherham, Hathersage, Baslow, Hope, Bakewell, Chesterfield, Pontefract, Wakefield, Retford, Worksop, Lincoln, Scunthorpe, Belton, Epworth, Gainsborough, Mansfield, Rochdale and Manchester
Areas of interest
Multiple Sclerosis; Headaches; Migraines; Epilepsy; Parkinson's disease; Movement Disorders; Stroke; Transient Ischaemic Attack; Medically Unexplained Symptoms; Driving Queries; Blackouts; Nerve pain; Peripheral Neuropathy; Ataxia; Motor Neurone Disease
Current NHS consultant posts held
Consultant Neurologist, Royal Hallamshire Hospital Sheffield
Consultant Neurologist, Doncaster Royal Infirmary
Use of technology in healthcare
Clinical trial infrastructure
Improving access of patients to clinical trials
I really enjoy teaching medical students, doctors in training, general practitioners and other neurologists.
I regularly give teaching sessions and I am the honorary strategic director of the MS Academy which aims to improve the care of all patients with MS in the UK by better education of health care practioners.
Outside of work I enjoy running and looking after my young family of 2 girls and a boy.
Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis (MS-SMART): A Phase 2b, Multiarm, Double-Blind, Randomised Placebo-Controlled Trial. Lancet Neurology 2020. Available at https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(19)30485-5.pdf
Wearable Sensors Can Reliably Quantify Gait Alterations Associated With Disability in People With Progressive Multiple Sclerosis in a Clinical Setting. J Neurology 2020 available at https://link.springer.com/article/10.1007/s00415-020-09928-8
Is a Wearable Sensor-Based Characterisation of Gait Robust Enough to Overcome Differences Between Measurement Protocols? Sensors 2020; available at www.mdpi.com/1424-8220/20/1/79
MS-SMART:a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119433/
Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review. J Neurol Sci. 2018 May 15;388:115-127
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937879/
Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.
Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602172/
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurology. 2016; 15:259-69
Axonal conduction in multiple sclerosis: A combined magnetic resonance imaging and electrophysiological study of the medial longitudinal fasciculus. Mult Scler. 2015 Jun;21(7):905-15
Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887342/
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain 2013; 136:2305-17
Energy failure in multiple sclerosis and its investigation using MR techniques. J Neurol 2011; 258:2113-27
Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope. J Am Geriatr Soc. 2010 Oct;58(10):2026-7
Courses offered to GPs
I have taken part in TARGET sessions in Doncaster.
I have offered bespoke teaching sessions to local general practises and happy to be approached for any other sessions.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://sheffieldacuk0-my.sharepoint.com/:b:/g/personal/d_j_paling_sheffield_ac_uk/EekJedPm-41KivwzrQJjMMYBQl4Mif2rKPQh-Sj0kR3bOw?e=k0KbzV
- PhD in Neurology University College London 2014
- Member of the Royal College of Physicians Royal College of Physicians, London 2006
- BSc first class with Honours in Biomedical Sciences University of Manchester 2000
- MB ChB University of Manchester 2003
- Multiple Sclerosis Academy Neurology Academy 2016
Reference number 6078639
Professional bodies (positions held - last 3 yrs)
- Chair of the Infrastructure Working Group Multiple Sclerosis Society 2018
- Honorary Strategic Director Multiple Sclerosis Academy 2017
- Honorary Senior Lecturer University of Sheffield 2014
- Clinical Lead MS Centre Sheffield 2015
Details of entry to specialist register
- Neurology, 2014
Affiliations / memberships
Member of the Association of British Neurologists
Member of the British Association for the Study of Headache
Faculty of the Multiple Sclerosis Academy
Member of the Royal College of Physicians
- Thorne RoadDONCASTERDN2 5TH
- 16:00 - 20:00
- 07450 019945
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details